过敏性鼻炎的过敏原免疫治疗的未来方向:专家的观点
Oliver Pfaar1, Jay Portnoy2, Hendrik Nolte3
1Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany.
The journal of allergy and clinical immunology. In practice
|September 16, 2023
概括
过敏原免疫疗法 (AIT) 是对过敏的关键治疗方法. 这份专家审查确定了AIT的7个未满足的需求和未来方向,包括新的应用路线和诊断工具.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏学 过敏学
- 临床医学 临床医学
背景情况:
- 过敏原免疫疗法 (AIT) 是对过敏的唯一疾病修饰治疗方法.
- 在优化AIT的有效性和应用方面存在重大未满足的需求.
研究的目的:
- 在过敏原免疫疗法 (AIT) 中解决7个关键的未满足需求.
- 提供专家对AIT未来方向和创新的观点.
主要方法:
- 一个国际专家组制定了AIT未来的7个关键方面.
- 进行了全面的文献审查.
- 在讨论的主题上建立了一个同意的立场.
主要成果:
- 确定了AIT进步的7个关键领域:替代途径,重组疫苗,AIT组成的组件解决诊断 (CRD),COVID-19疫苗接种的影响,将生物与AIT结合起来,高风险人群的创新以及监管考虑.
- 作者详细阐述了他们对每个方面的专家意见和立场.
结论:
- 解决这些7个未满足的需求对于推进过敏原免疫疗法至关重要.
- 在AIT的未来创新需要探索新的方法,诊断和监管框架.
相关概念视频
Allergic Reactions
27.7K
Overview
27.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
332
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
332
Drugs Used in Lower Respiratory Disorders: Overview
481
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
481
Asthma: Pathogenesis and Management
439
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
439
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K


